Patients’ Access to 2018 FDA-Approved Drugs 1 Year Post Approval
2018 was a landmark year for new drug approvals. However, patients’ access to these novel drugs varied by drug category and enrolled health plan.
Variation in US Private Health Plans’ Coverage of Orphan Drugs
Health plans restrict orphan drug coverage less often than nonorphan drug coverage. However, the frequency of restrictions varies considerably across plans.
